Leash Biosciences

Predicts how strongly a small-molecule compound will bind to a target protein using physics-informed machine learning models. Provides quantitative binding affinity scores that prioritize compounds for experimental validation.

Predicts absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of drug candidates to identify compounds with favorable pharmacokinetic profiles. Enables early filtering of compounds with poor drug-like properties.

Evaluates selectivity of compounds across multiple related protein targets to identify compounds with desired selectivity profiles. Predicts binding to off-targets and related proteins to guide selectivity optimization.

Evaluates the synthetic feasibility and complexity of predicted compounds to guide selection of compounds that are practical to synthesize. Estimates synthetic routes and identifies compounds with high synthetic difficulty.

Provides interpretable, physics-informed explanations of predicted binding interactions rather than black-box predictions. Reveals which molecular features drive binding affinity and enables rational design iteration.

Ranks and prioritizes large compound libraries based on predicted binding affinity and ADMET properties, enabling efficient allocation of experimental resources to most promising candidates. Integrates multiple prediction models into actionable prioritization scores.

Analyzes protein structures and sequences to characterize druggability, binding site properties, and suitability for small-molecule targeting. Provides insights into whether a protein target is amenable to computational drug discovery approaches.

Builds quantitative structure-activity relationship (QSAR) models from experimental data to predict activity of new compounds and guide iterative optimization. Learns patterns between chemical structure and biological activity.

Integrates with existing computational chemistry and drug discovery workflows, enabling seamless incorporation of AI predictions into established pipelines. Provides APIs and data format compatibility for workflow automation.

Recommends which predicted compounds should be prioritized for wet lab validation based on confidence scores and predicted properties. Guides experimental design by identifying compounds most likely to succeed.

Predicts potential off-target binding and toxicity risks by assessing compound interactions with non-target proteins and known toxicity mechanisms. Identifies compounds with high risk of adverse effects.

Generates or recommends structural analogs and chemical series expansions around known active compounds. Suggests modifications to improve binding affinity, selectivity, or ADMET properties while maintaining core activity.